CStone Pharmaceuticals' market value is the price at which a share of CStone Pharmaceuticals trades on a public exchange. It measures the collective expectations of CStone Pharmaceuticals investors about its performance. CStone Pharmaceuticals is trading at 0.7 as of the 14th of February 2026. This is a 2.78 percent down since the beginning of the trading day. The stock's lowest day price was 0.7. With this module, you can estimate the performance of a buy and hold strategy of CStone Pharmaceuticals and determine expected loss or profit from investing in CStone Pharmaceuticals over a given investment horizon. Check out CStone Pharmaceuticals Correlation, CStone Pharmaceuticals Volatility and CStone Pharmaceuticals Performance module to complement your research on CStone Pharmaceuticals.
It's important to distinguish between CStone Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CStone Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CStone Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
CStone Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CStone Pharmaceuticals' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CStone Pharmaceuticals.
0.00
11/16/2025
No Change 0.00
0.0
In 3 months and 1 day
02/14/2026
0.00
If you would invest 0.00 in CStone Pharmaceuticals on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding CStone Pharmaceuticals or generate 0.0% return on investment in CStone Pharmaceuticals over 90 days. CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precis... More
CStone Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CStone Pharmaceuticals' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CStone Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for CStone Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CStone Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use CStone Pharmaceuticals historical prices to predict the future CStone Pharmaceuticals' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CStone Pharmaceuticals. Your research has to be compared to or analyzed against CStone Pharmaceuticals' peers to derive any actionable benefits. When done correctly, CStone Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CStone Pharmaceuticals.
CStone Pharmaceuticals February 14, 2026 Technical Indicators
CStone Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0717, which signifies that the company had a -0.0717 % return per unit of risk over the last 3 months. CStone Pharmaceuticals exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CStone Pharmaceuticals' Risk Adjusted Performance of (0.05), standard deviation of 4.01, and Mean Deviation of 1.23 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.43, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CStone Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, CStone Pharmaceuticals is likely to outperform the market. At this point, CStone Pharmaceuticals has a negative expected return of -0.3%. Please make sure to confirm CStone Pharmaceuticals' jensen alpha, rate of daily change, as well as the relationship between the Rate Of Daily Change and period momentum indicator , to decide if CStone Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation
0.00
No correlation between past and present
CStone Pharmaceuticals has no correlation between past and present. Overlapping area represents the amount of predictability between CStone Pharmaceuticals time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CStone Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current CStone Pharmaceuticals price fluctuation can be explain by its past prices.
Other Information on Investing in CStone Pink Sheet
CStone Pharmaceuticals financial ratios help investors to determine whether CStone Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CStone with respect to the benefits of owning CStone Pharmaceuticals security.